SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DYAX: Dyax Corp. -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (154)2/29/2008 1:05:31 PM
From: DewDiligence_on_SI  Read Replies (1) | Respond to of 197
 
This ought to be one of the lamest PRs ever.

Not even close, IMHO. I’ve seen literally hundreds that were worse just in biotech.

WYE will argue that Xyntha is safer than Baxter’s Advate because of the filtration process. It probably makes no difference from a medical standpoint, but DYAX’s contribution is important for the product’s marketing. Regards, Dew



To: Pseudo Biologist who wrote (154)2/29/2008 3:41:27 PM
From: nigel bates  Read Replies (1) | Respond to of 197
 
Yep, clearly it's rubbish.

- but I'm pleasantly surprised by the quality of those watching the stock here.

:)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News